What is Microgen?
Microgen Laboratories is at the forefront of developing rapid, user-friendly, and economical pathogen detection kits. These advanced diagnostic tools are engineered to swiftly identify a spectrum of viruses, bacteria, and fungi across diverse environmental settings. With a specific focus on critical public health concerns such as CMV, HSV, and syphilis, Microgen's solutions are vital for healthcare providers and researchers seeking efficient diagnostic capabilities. The company's commitment to addressing significant infectious disease challenges aims to enhance patient care and reduce overall healthcare expenditures.
How much funding has Microgen raised?
Microgen has raised a total of $25K across 1 funding round:
Debt
$25K
Debt (2021): $25K with participation from PPP
Key Investors in Microgen
PPP
Public-Private Partnership
What's next for Microgen?
The substantial expansion capital secured by Microgen Laboratories signals a pivotal growth phase, likely indicating a Series B or C stage of development. This strategic financing is expected to fuel advancements in product development, market penetration, and operational scaling. The company is poised to further solidify its market presence by enhancing its diagnostic kit offerings and expanding its reach to a broader customer base, thereby reinforcing its role in public health diagnostics.
See full Microgen company page
